Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Concetta Fargnoli

Showing results (201-210 of 284) with videos related to

Pageof 29
Sort By:
European Journal of Dermatology : EJD|March 2, 2021
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasisAndrea Chiricozzi, Antonio Costanzo, Maria Concetta Fargnoli, et al.
Plos One|January 10, 2013
On the interplay of telomeres, nevi and the risk of melanomaClara Bodelon, Ruth M Pfeiffer, Valentina Bollati, et al.
American Journal of Clinical Dermatology|August 19, 2023
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of ObservationAndrea Chiricozzi, Michela Ortoncelli, Donatella Schena, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2019
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019Claus Garbe, Teresa Amaral, Ketty Peris, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2020
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019Claus Garbe, Teresa Amaral, Ketty Peris, et al.
American Journal of Clinical Dermatology|June 15, 2023
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of ObservationAndrea Chiricozzi, Michela Ortoncelli, Donatella Schena, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinomaAlice Baggi, Pietro Quaglino, Marco Rubatto, et al.
Clinical and Experimental Dermatology|June 16, 2025
Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective studyFrancesca Satolli, Silvia Gerosa, Martina Burlando, et al.
The British Journal of Dermatology|December 13, 2023
Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensusElvira Moscarella, Eugenia Veronica Di Brizzi, Paolo Alpi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2019
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelinesKetty Peris, Maria Concetta Fargnoli, Claus Garbe, et al.
Pageof 29

Showing results (201-210 of 284) with videos related to

Sort By:
Pageof 29
European Journal of Dermatology : EJD|March 2, 2021
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasisAndrea Chiricozzi, Antonio Costanzo, Maria Concetta Fargnoli, et al.
Plos One|January 10, 2013
On the interplay of telomeres, nevi and the risk of melanomaClara Bodelon, Ruth M Pfeiffer, Valentina Bollati, et al.
American Journal of Clinical Dermatology|August 19, 2023
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of ObservationAndrea Chiricozzi, Michela Ortoncelli, Donatella Schena, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2019
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019Claus Garbe, Teresa Amaral, Ketty Peris, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2020
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019Claus Garbe, Teresa Amaral, Ketty Peris, et al.
American Journal of Clinical Dermatology|June 15, 2023
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of ObservationAndrea Chiricozzi, Michela Ortoncelli, Donatella Schena, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinomaAlice Baggi, Pietro Quaglino, Marco Rubatto, et al.
Clinical and Experimental Dermatology|June 16, 2025
Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective studyFrancesca Satolli, Silvia Gerosa, Martina Burlando, et al.
The British Journal of Dermatology|December 13, 2023
Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensusElvira Moscarella, Eugenia Veronica Di Brizzi, Paolo Alpi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2019
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelinesKetty Peris, Maria Concetta Fargnoli, Claus Garbe, et al.
Pageof 29